And more good news for women with perinatal mood and anxiety disorders… The 21st Century Cures Act passed by the U.S. House of Representatives last week has now gained approval from the Senate. This legislation [...]
This article in Psychiatric Times reviews some interesting research which suggests that drugs which modulate the estrogen receptor may improve cognitive functioning in patients with schizophrenia. This is the first study to show that oral [...]
We get many questions about the interaction between lamotrigine (Lamictal) and oral contraceptives (OCs). While many readers raise concerns that lamotrigine may decrease the effectiveness of oral contraceptives, the primary interaction is actually in [...]
New Research from the CWMH: Omega-3 Fatty Acids for Atypical Antipsychotic-Associated Hypertriglyceridemia
Dyslipidemia is a common side effect of atypical antipsychotics and, for a significant number of patients, may limit the acceptabillily of this class of drugs as an option for long-term treatment. This open trial tested [...]
Many women have concerns about the side effects of oral contraceptives (birth control pills). Potential side effects include bloating, breast tenderness, and weight gain. In addition, some women may experience depression or mood swings, side [...]
Lithium is one of the most effective treatments for patients with bipolar disorder. Its use, however, is limited by its potential for serious long-term adverse events, including renal, thyroid, and parathyroid dysfunction. A recent study [...]
Women with bipolar disorder often experience fluctuating mood symptoms across the menstrual cycle, typically reporting an exacerbation of symptoms during the premenstrual phase of the cycle (Rasgon et al, 2003, 2005). Other studies have indicated [...]
Several years ago, we reviewed a paper suggesting that estrogen may be a beneficial treatment for women with schizophrenia. In this study, patients with schizophrenia were treated with estrogen. There was significant improvement in their [...]
Many studies have examined the association between parental age and psychiatric illness in the children, including autism and schizophrenia. In a recent case-control study from Finland, the authors identified 10,409 individuals with ADHD born between 1991 and 2005 from nationwide population-based registers. Logistic regression was used to examine the association between parental age and ADHD in the offspring, adjusting for potential confounding factors including parental psychiatric history, maternal socioeconomic status, marital status, maternal smoking during pregnancy, number of previous births, and birth weight.
Maternal depression has been identified as a risk factor for adolescent depression. In addition, maternal depression appears to increase the risk of certain behavioral problems in children; however, it appears that the timing of exposure may play an important role in mediating the effects of maternal depression. A recent study suggests that childhood exposure to maternal depression between the ages of 4 and 14 may result in risky behaviors later on during adolescence.